Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Luciferases, Firefly | 12 | 2020 | 17 | 4.540 |
Why?
|
Firefly Luciferin | 8 | 2023 | 8 | 4.270 |
Why?
|
Benzothiazoles | 9 | 2019 | 19 | 3.580 |
Why?
|
Fluorescent Dyes | 7 | 2019 | 196 | 2.610 |
Why?
|
Luminescent Measurements | 6 | 2020 | 39 | 1.640 |
Why?
|
Alkanesulfonates | 4 | 2012 | 4 | 1.510 |
Why?
|
Molecular Structure | 13 | 2019 | 374 | 1.460 |
Why?
|
Luminescent Agents | 4 | 2015 | 6 | 1.420 |
Why?
|
Sulfonic Acids | 3 | 2017 | 6 | 1.290 |
Why?
|
Luminescence | 3 | 2019 | 18 | 1.270 |
Why?
|
Oxazines | 3 | 2018 | 13 | 1.130 |
Why?
|
Amidohydrolases | 4 | 2023 | 35 | 0.970 |
Why?
|
Luciferases | 5 | 2021 | 106 | 0.880 |
Why?
|
Monoacylglycerol Lipases | 1 | 2023 | 2 | 0.860 |
Why?
|
Esters | 4 | 2017 | 18 | 0.820 |
Why?
|
Coenzyme A Ligases | 2 | 2019 | 10 | 0.820 |
Why?
|
Substrate Specificity | 7 | 2019 | 333 | 0.790 |
Why?
|
Rhodamines | 2 | 2019 | 20 | 0.790 |
Why?
|
Esterases | 2 | 2011 | 13 | 0.740 |
Why?
|
Coloring Agents | 2 | 2011 | 53 | 0.720 |
Why?
|
Optical Imaging | 3 | 2015 | 68 | 0.660 |
Why?
|
Coumarins | 1 | 2019 | 6 | 0.640 |
Why?
|
Cricetulus | 6 | 2017 | 99 | 0.620 |
Why?
|
Fluorescence | 1 | 2019 | 83 | 0.610 |
Why?
|
Organosilicon Compounds | 1 | 2018 | 4 | 0.610 |
Why?
|
CHO Cells | 6 | 2017 | 189 | 0.610 |
Why?
|
Enzyme Inhibitors | 2 | 2023 | 349 | 0.610 |
Why?
|
Silicon | 1 | 2018 | 19 | 0.610 |
Why?
|
Sulfonamides | 1 | 2019 | 121 | 0.590 |
Why?
|
Fireflies | 3 | 2014 | 3 | 0.570 |
Why?
|
Evolution, Molecular | 1 | 2019 | 298 | 0.570 |
Why?
|
Glutathione | 1 | 2017 | 54 | 0.540 |
Why?
|
Glossectomy | 1 | 2016 | 3 | 0.530 |
Why?
|
Animals | 17 | 2021 | 19601 | 0.530 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2016 | 54 | 0.490 |
Why?
|
Amides | 1 | 2015 | 52 | 0.480 |
Why?
|
Piperidines | 1 | 2015 | 54 | 0.480 |
Why?
|
Pyridines | 1 | 2015 | 98 | 0.470 |
Why?
|
Thiazoles | 1 | 2014 | 46 | 0.440 |
Why?
|
Robotic Surgical Procedures | 1 | 2016 | 115 | 0.440 |
Why?
|
Spectrometry, Fluorescence | 2 | 2018 | 90 | 0.430 |
Why?
|
Trifluoroacetic Acid | 1 | 2012 | 1 | 0.420 |
Why?
|
Neuroimaging | 1 | 2014 | 143 | 0.400 |
Why?
|
Light | 2 | 2010 | 198 | 0.390 |
Why?
|
HeLa Cells | 4 | 2017 | 523 | 0.360 |
Why?
|
Brain | 2 | 2016 | 1487 | 0.350 |
Why?
|
Solvents | 2 | 2010 | 57 | 0.350 |
Why?
|
Drosophila melanogaster | 1 | 2014 | 481 | 0.330 |
Why?
|
rho GTP-Binding Proteins | 1 | 2009 | 18 | 0.330 |
Why?
|
Cysteine | 2 | 2013 | 107 | 0.300 |
Why?
|
Fluorescein | 1 | 2007 | 13 | 0.290 |
Why?
|
Biophysics | 1 | 2007 | 41 | 0.280 |
Why?
|
Mice | 7 | 2021 | 10251 | 0.280 |
Why?
|
Tissue Distribution | 2 | 2020 | 287 | 0.280 |
Why?
|
Oxidation-Reduction | 2 | 2018 | 302 | 0.270 |
Why?
|
Guanine | 1 | 2004 | 23 | 0.230 |
Why?
|
Peptide Library | 1 | 2004 | 35 | 0.230 |
Why?
|
Biomimetics | 1 | 2004 | 28 | 0.230 |
Why?
|
Kinetics | 3 | 2014 | 750 | 0.220 |
Why?
|
Structure-Activity Relationship | 2 | 2018 | 363 | 0.220 |
Why?
|
Serine | 1 | 2023 | 83 | 0.210 |
Why?
|
Oxygen | 2 | 2018 | 313 | 0.210 |
Why?
|
Ligands | 1 | 2004 | 410 | 0.210 |
Why?
|
Cricetinae | 2 | 2014 | 365 | 0.200 |
Why?
|
Period Circadian Proteins | 1 | 2021 | 71 | 0.190 |
Why?
|
Solubility | 2 | 2012 | 176 | 0.180 |
Why?
|
Biocatalysis | 1 | 2019 | 45 | 0.170 |
Why?
|
Electrons | 1 | 2019 | 34 | 0.160 |
Why?
|
Circadian Rhythm | 1 | 2021 | 373 | 0.150 |
Why?
|
Catalysis | 1 | 2018 | 151 | 0.150 |
Why?
|
Coleoptera | 1 | 2017 | 6 | 0.150 |
Why?
|
Palladium | 1 | 2017 | 4 | 0.140 |
Why?
|
Quinones | 1 | 2017 | 5 | 0.140 |
Why?
|
Alkenes | 1 | 2017 | 3 | 0.140 |
Why?
|
Congenital Abnormalities | 1 | 2017 | 23 | 0.140 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 128 | 0.140 |
Why?
|
Water | 1 | 2019 | 300 | 0.140 |
Why?
|
Ear, Inner | 1 | 2017 | 16 | 0.140 |
Why?
|
Potassium | 1 | 2017 | 100 | 0.140 |
Why?
|
Cochlear Implantation | 1 | 2017 | 26 | 0.140 |
Why?
|
Speech Perception | 1 | 2017 | 79 | 0.130 |
Why?
|
Capillary Permeability | 1 | 2015 | 15 | 0.120 |
Why?
|
Photochemical Processes | 1 | 2015 | 14 | 0.120 |
Why?
|
Mutation | 3 | 2014 | 2452 | 0.120 |
Why?
|
Enzyme Assays | 1 | 2015 | 14 | 0.120 |
Why?
|
Hydrolysis | 1 | 2015 | 140 | 0.120 |
Why?
|
Blood-Brain Barrier | 1 | 2015 | 81 | 0.120 |
Why?
|
Amination | 1 | 2014 | 2 | 0.120 |
Why?
|
Humans | 8 | 2018 | 59280 | 0.120 |
Why?
|
Mice, Transgenic | 2 | 2014 | 1204 | 0.110 |
Why?
|
Chromophore-Assisted Light Inactivation | 1 | 2012 | 1 | 0.100 |
Why?
|
Biological Transport | 1 | 2014 | 288 | 0.100 |
Why?
|
Nitriles | 1 | 2013 | 62 | 0.100 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2012 | 39 | 0.100 |
Why?
|
Peptide Hydrolases | 1 | 2013 | 78 | 0.100 |
Why?
|
Cell Survival | 1 | 2014 | 559 | 0.100 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 234 | 0.090 |
Why?
|
Cell Membrane Permeability | 1 | 2011 | 39 | 0.090 |
Why?
|
Stereoisomerism | 1 | 2010 | 67 | 0.090 |
Why?
|
Nitrobenzenes | 1 | 2009 | 2 | 0.080 |
Why?
|
Phenylacetates | 1 | 2009 | 3 | 0.080 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 656 | 0.080 |
Why?
|
Guanosine Diphosphate | 1 | 2009 | 19 | 0.080 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2009 | 21 | 0.080 |
Why?
|
Swine | 1 | 2011 | 352 | 0.080 |
Why?
|
Guanosine Triphosphate | 1 | 2009 | 50 | 0.080 |
Why?
|
Cells, Cultured | 1 | 2014 | 2089 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 292 | 0.080 |
Why?
|
Ultraviolet Rays | 1 | 2009 | 127 | 0.080 |
Why?
|
Adenosine Triphosphate | 1 | 2010 | 289 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 488 | 0.070 |
Why?
|
Photochemistry | 1 | 2007 | 23 | 0.070 |
Why?
|
Organic Chemicals | 1 | 2007 | 22 | 0.070 |
Why?
|
Chromatography, Gel | 1 | 2007 | 65 | 0.070 |
Why?
|
Models, Chemical | 1 | 2007 | 135 | 0.070 |
Why?
|
Time Factors | 2 | 2017 | 3614 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 1093 | 0.060 |
Why?
|
Exocytosis | 1 | 2004 | 59 | 0.060 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 1552 | 0.060 |
Why?
|
Cytoskeleton | 1 | 2004 | 137 | 0.050 |
Why?
|
Mass Spectrometry | 1 | 2004 | 295 | 0.050 |
Why?
|
Actins | 1 | 2004 | 258 | 0.050 |
Why?
|
Suprachiasmatic Nucleus | 1 | 2021 | 141 | 0.040 |
Why?
|
Phenotype | 1 | 2004 | 1136 | 0.040 |
Why?
|
Infrared Rays | 1 | 2017 | 16 | 0.040 |
Why?
|
Speech Production Measurement | 1 | 2017 | 8 | 0.040 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2017 | 31 | 0.030 |
Why?
|
Cochlea | 1 | 2017 | 22 | 0.030 |
Why?
|
Cochlear Implants | 1 | 2017 | 30 | 0.030 |
Why?
|
Micrococcal Nuclease | 1 | 1996 | 13 | 0.030 |
Why?
|
Enzyme Stability | 1 | 1996 | 46 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2017 | 85 | 0.030 |
Why?
|
Proline | 1 | 1996 | 42 | 0.030 |
Why?
|
Thrombin | 1 | 2013 | 21 | 0.030 |
Why?
|
Caspase 7 | 1 | 2013 | 18 | 0.030 |
Why?
|
Oligopeptides | 1 | 2013 | 128 | 0.030 |
Why?
|
Caspase 3 | 1 | 2013 | 103 | 0.030 |
Why?
|
Infant | 1 | 2017 | 1486 | 0.020 |
Why?
|
Female | 3 | 2021 | 30694 | 0.020 |
Why?
|
Child, Preschool | 1 | 2017 | 1782 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2017 | 2337 | 0.020 |
Why?
|
Risk Assessment | 1 | 2017 | 1920 | 0.020 |
Why?
|
Male | 2 | 2021 | 27726 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 1368 | 0.020 |
Why?
|
Apoptosis | 1 | 2013 | 1032 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 5283 | 0.020 |
Why?
|
Chemistry, Physical | 1 | 1996 | 47 | 0.010 |
Why?
|
Isomerism | 1 | 1996 | 28 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 1996 | 58 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1996 | 94 | 0.010 |
Why?
|
Crystallization | 1 | 1996 | 97 | 0.010 |
Why?
|
Thermodynamics | 1 | 1996 | 191 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1996 | 253 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1996 | 447 | 0.010 |
Why?
|
Protein Conformation | 1 | 1996 | 763 | 0.010 |
Why?
|
Models, Molecular | 1 | 1996 | 1128 | 0.010 |
Why?
|